title: Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials.
authors.affiliation: JDRF, New York, New York, USA.
authors.forename: Teodora P
authors.initials: TP
authors.lastname: Staeva
authors.forename: Lucienne
authors.initials: L
authors.lastname: Chatenoud
authors.forename: Richard
authors.initials: R
authors.lastname: Insel
authors.forename: Mark A
authors.initials: MA
authors.lastname: Atkinson
mesh_terms: D001324:Autoantigens / Q000276:immunology; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy; D050417:Insulin-Secreting Cells / Q000276:immunology; D012107:Research Design
chemical_list: D001324:Autoantigens; D007166:Immunosuppressive Agents